Resultados de su búsqueda "Nose Bleeds".
FRIDAY, Dec. 12, 2025 (HealthDay News) — More than half of people with a rare life-threatening bleeding condition received lasting relief from an experimental antibody treatment, clinical trial results show.
Ianalumab, a monoclonal antibody, helped patients with immune thrombocytopenia (ITP) maintain safe platelet counts without serious bleeding episodes for at least a year, accordi...